Skip to main content

Table 3 Comparison of survival, recurrence, and metastasis rates between the two groups after 3 years of treatment [n(%)]

From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects

Category

Group A (n=66)

Group B (n=70)

χ2 value

p value

Survival rate

47 (77.27)

60 (85.71)

4.259

0.039

Recurrence rate

13 (19.70)

5 (7.14)

4.662

0.030

Metastasis rate

15 (22.73)

7 (10.00)

4.058

0.044